Literature DB >> 3417235

A longitudinal follow-up of asymptomatic hepatitis B surface antigen-positive Chinese children.

A S Lok1, C L Lai.   

Abstract

Fifty-one asymptomatic Chinese hepatitis B surface antigen (HBsAg) carrier children (34 boys, 17 girls), age 1 to 15 years (median: 10 years), were prospectively followed for up to 4 years (median: 30 months) to determine the natural evolution of clinical, biochemical and virological features during the early phase of chronic hepatitis B virus infection. Hepatomegaly was the only abnormal finding on examination, being present in five children initially and four at follow-up. Serum ALT levels were normal in 80% of the children at presentation and remained within the normal range during the study in 60%. Fluctuations in ALT levels were mild. In four of 12 instances, transient elevations in ALT levels were associated with a fall in serum hepatitis B virus DNA levels. At presentation, 43 (84%) children were hepatitis B e antigen (HBeAg) positive; only two (7%) cleared HBeAg on follow-up. None of the eight children who were initially positive for the antibody to HBeAg reverted back to HBeAg positivity. All the children remained HBsAg positive. In this study, we demonstrated that chronic hepatitis B virus infection in asymptomatic Chinese children is usually associated with a mild and stable liver disease despite high levels of hepatitis B virus replication. This may reflect an immunological tolerance to the hepatitis B virus induced by early exposure to the virus and accounts for the persistently high levels of hepatitis B virus replication on follow-up.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3417235     DOI: 10.1002/hep.1840080527

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  27 in total

1.  Diagnostic accuracy of serum biochemical fibrosis markers in children with chronic hepatitis B evaluated by receiver operating characteristics analysis.

Authors:  Dariusz Marek Lebensztejn; Elzbieta Skiba; Jolanta Tobolczyk; Maria Elzbieta Sobaniec-Lotowska; Maciej Kaczmarski
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

2.  HBV-DNA-related hepatocellular carcinoma occurring in childhood. Report of three cases.

Authors:  R Giacchino; C Navone; F Facco; G Giambartolomei; P Pontisso; F Callea
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

3.  Management of chronic hepatitis B: Canadian Association for the Study of the Liver consensus guidelines.

Authors:  Carla S Coffin; Scott K Fung; Mang M Ma
Journal:  Can J Gastroenterol       Date:  2012-12       Impact factor: 3.522

Review 4.  Natural history of chronic hepatitis B: phases in a complex relationship.

Authors:  Catherine M N Croagh; John S Lubel
Journal:  World J Gastroenterol       Date:  2014-08-14       Impact factor: 5.742

Review 5.  KASL clinical practice guidelines: management of chronic hepatitis B.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 6.  Viral hepatitis.

Authors:  G V Gregorio; G Mieli-Vergani; A P Mowat
Journal:  Arch Dis Child       Date:  1994-04       Impact factor: 3.791

7.  A pregnant patient with a positive hepatitis B surface antigen.

Authors:  Arjmand Rasool Mufti; Nancy Reau
Journal:  Frontline Gastroenterol       Date:  2012-08-31

8.  Natural history of hepatitis B in perinatally infected carriers.

Authors:  E H Boxall; J Sira; R A Standish; P Davies; E Sleight; A P Dhillon; P J Scheuer; D A Kelly
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-09       Impact factor: 5.747

9.  The management of chronic viral hepatitis: A Canadian consensus conference 2004.

Authors:  Morris Sherman; Vincent Bain; Jean-Pierre Villeneuve; Robert P Myers; Curtis Cooper; Steven Martin; Catherine Lowe
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

10.  Acute hepatitis B or exacerbation of chronic hepatitis B-that is the question.

Authors:  Efrat Orenbuch-Harroch; Liran Levy; Eldad Ben-Chetrit
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.